Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Dakduif
    Junior Member
    • Mar 2013
    • 6

    New alignment algorithm in the works, feedback needed!

    Hello everybody,

    I am not sure if this is the correct place to post this, so please let me know if I should (re)move this.

    I'm a Master student from the Netherlands and I'm working on my graduate internship. I'm a biologist, but I have decided to do a more commercial-oriented Master track instead (yes, my friends call me a sell-out. )
    The company I am currently doing my internship at is working on a new bioinformatics tool that kind of blew my mind when I first heard about its specs and potential. My task here is to perform a market research for this product and eventually write my thesis about the results (it is the perfect combination of my biology, IT and communications/commercial applications nerd-love.)

    Before getting into too much detail about the commercial side, here's the thing: would SEQAnswers be a correct place to link to the survey I've created? The questions mostly focus on NGS data use within a respondent's company, the kind of alignment and variant calling software currently used, what problems are experienced in using this software and the average volume of NGS data that is analysed per month.

    Other feedback that I'm looking for is the preference for using open-source tools (we're still juggling with whether, and to what extent, to make the tool open-source) and what the most used OS is for bioinformatics (we're running openSUSE right now, but if everyone else ends up using Red Hat for example, we might switch to that instead.)

    In the same link there will be more info on what the tool does exactly plus more information about the company I'm working at (in order to not turn this into an advertisement. I haven't lurked here enough to see whether that would be allowed, so I decided not to for the moment..)

    I thought that the Bioinformatics topic would be the best place for reaching out to the people with the most knowledge about this subject.
    Unfortunately, I can't say anything about the technical side. Not only is that not my area, it's also still confidential information.
    Instead, I need complaints. Lots of them. Áll the complaints and disgruntlements you might have about your current alignment and variant calling software tools. And then spill these in the survey. ("Lekker zeiken" as we would say in the Netherlands.)

    So, feedback on this? Would it be okay to share the link?

    -Charlotte
    -Proud to be a slightly stressed-out graduate intern.
    Also a: biologist, mycologist, botanist, palaeoecologist, typer-happy, and all-round nerd.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
217 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
81 views
0 reactions
Last Post SEQadmin2  
Working...